Safety and efficacy against mange and nematodes of three formulations of abamectin in Arabian camels.
Shubber
A H
AH
Ancare NZ, PO Box 36240, Northcote, Auckland, New Zealand.
Oxley
K J
KJ
Khalaf
A M
AM
Ramahi
H M
HM
Al-Naqeeb
L M
LM
Karimi
O
O
Jamshidi
K
K
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000818:Animals; D000969:Antinematodal Agents / Q000008:administration & dosage*; D002162:Camelus; D002626:Chemistry, Pharmaceutical; D004305:Dose-Response Relationship, Drug; D005243:Feces / Q000469:parasitology; D005260:Female; D007267:Injections / Q000662:veterinary; D007306:Insecticides / Q000008:administration & dosage*; D007559:Ivermectin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D008297:Male; D009348:Nematoda; D009349:Nematode Infections / Q000188:drug therapy / Q000662:veterinary*; D012520:Sarcoptes scabiei; D012532:Scabies / Q000188:drug therapy / Q000662:veterinary*; D012867:Skin / Q000469:parasitology; D016896:Treatment Outcome
D000969:Antinematodal Agents; D007306:Insecticides; C048324:abamectin; D007559:Ivermectin